Addpharma Inc.

This trial is testing whether a new formulation of a drug for benign prostatic hyperplasia (enlarged prostate) works the same as the existing version. Healthy adult male volunteers receive a single dose of each formulation after a meal, and researchers compare how much drug gets …

This trial tests three different tablet versions of an experimental drug called AD-234 in healthy adults aged 19 to 50. The goal is to see which formulation best controls stomach acid levels over 24 hours after a week of daily dosing. Researchers will also compare how the body ab…

This trial compares a new formulation (AD-116A) of a drug used for benign prostatic hyperplasia to the original version (AD-1161) in healthy adult male volunteers. The goal is to see if the two formulations are bioequivalent—meaning they work the same way in the body. Participant…

This early-stage trial will test two experimental drugs, AD-2321 and AD-2322, in 41 healthy adults to see how they interact in the body. The study focuses on safety and how the drugs are processed, not on treating high blood pressure. Results will guide future studies in patients…

This early-stage trial will test a new drug formulation (AD-117) for mixed dyslipidemia, a condition involving high cholesterol and triglycerides. Sixty healthy adults will receive a single dose of either the new or a reference formulation to compare how the body processes each. …

This study tests a new drug called AD-211 to find the best dose for easing knee pain from osteoarthritis. About 200 people with knee osteoarthritis will take part in this double-blind, placebo-controlled trial. The main goal is to measure pain reduction during activity over 24 ho…

This early-stage trial is testing two experimental oral drugs, AD-236A and AD-236B, in healthy adult volunteers. The goal is to see how the drugs interact when taken together and whether the combination is safe. The study involves 44 participants aged 19 to 55 and will measure dr…

This study tests two different formulations of an experimental drug called AD-118 in healthy adults aged 19 to 64. Participants receive a single dose of each version in a random order, and researchers measure how the drug moves through the body and check for side effects. The goa…

This early-stage trial will test a new drug called AD-230 in 24 healthy adults to see how food changes the way the body processes it. Participants will take the drug once after eating and once on an empty stomach. The goal is to gather safety and dosing information for future stu…

This early-stage study will test a new experimental drug called AD-231 in 60 healthy adults. The goal is to see how safe the drug is and how the body processes it, not to treat any disease. Participants will receive a single dose of the drug and have their blood levels measured o…

This early-stage trial will test a new tablet called AD-123 in 50 healthy adults. Researchers want to see if taking one AD-123 pill works similarly to taking two separate pills (AD-1231 and AD-1232) together. The study focuses on safety and how the drug moves through the body, no…

This early-stage trial will test a new drug called AD-230 in 52 healthy adults to see how the body processes it and whether it is safe. The study uses a crossover design where each participant receives both AD-230 and a related version. Results will help decide if AD-230 should m…

This early-stage study will test two versions of a drug (AD-118 and AD-1181) in 70 healthy adults to see how they are processed by the body and if they are safe. Participants will receive a single dose of each version under fasting conditions. The study does not aim to treat any …

This early-stage study compares two versions of a drug for gastritis, a condition that causes stomach inflammation. Researchers will give 28 healthy adults both forms of the drug at different times to see which one is safer and how the body processes it. The goal is to gather inf…

This early-stage study will test three experimental drugs (AD-231A, AD-231B, and AD-231C) in 55 healthy adults to see how they interact in the body and if they are safe. The drugs are being developed for high blood pressure and high cholesterol. Participants must be between 19 an…